A recent study also reported patients with tumors harboring FUT4-high expression were associated with worse progression-free survival (PFS), indicating FUT4 as a potential prognostic factor for CRC patients.20 Therefore, these observations would indicate a potential FUT4-dependent prognostic value for miR-26a/26b which needs to be further confirmed in forthcoming studies. The gene discussed is FUT4; the disease is colorectal carcinoma.